Healthcare -
Biotechnology - NASDAQ - US
$ 5.59
1.64 %
$ 343 M
Market Cap
-3.14
P/E
GLUE - CAPITAL EXPENDITURES
Capital Expenditures GLUE - Monte Rosa Therapeutics, Inc.
-19 M
LAST VALUE
-39.88%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR